-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Bionik Laboratories Corp. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2012 to Q2 2022.
- Bionik Laboratories Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending June 30, 2022 was $500K, a 9.09% decline year-over-year.
- Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2.05M, a 63.1% decline from 2021.
- Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $5.55M, a 87.3% increase from 2020.
- Bionik Laboratories Corp. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $2.96M, a 73.2% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)